Consano Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-20.
Consano Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 20, 2026. Consano Bio, Inc. was formerly named Consano Biologics, LLC. The filing reports $34.82M sold. Its industry group is Biotechnology. It names Andrew Hall (Chief Executive Officer and Secretary of Issuer), Jennifer Schmitke (President and Chief Operating Officer of Issuer), Doug Weide (Director) (SEC Form D, March 20, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Consano Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-03-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Consano Bio, Inc.
Free to see. No signup.
More on the people and the money behind Consano Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in March 2026, largest first.
Get an email when Consano Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Consano Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Consano Bio, Inc. →Get the full cited report on Consano Bio, Inc.
What the filing shows about Consano Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Consano Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Consano Bio, Inc.'s address as 100 Summit Drive, Burlington, MA 01803.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Consano Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Consano Bio, Inc. is a registered filer with the SEC (CIK 1981285) and has filed since 2023-06-13. 3 filings are on record, the latest on 2026-03-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Consano Bio, Inc.'s Form D of 2026-03-20 names Andrew Hall, Jennifer Schmitke, Doug Weide and 6 more as its officers, directors or promoters.
Its new offerings report $59.56M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $34.82M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Andrew Hall is named as Chief Executive Officer and Secretary of Issuer on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
On the filing as: Executive Officer.
Jennifer Schmitke is named as President and Chief Operating Officer of Issuer on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
Doug Weide is named as Director on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
Christopher Centeno is named as Director on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
Bill Abbington is named as Director on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
Jerome Adams is named as Director on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
Michael Pede is named as Director on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
Joe Schiesl is named as Director on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
John Conway is named as Director on the Form D that Consano Bio, Inc. filed with the SEC on 20 March 2026, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role and 7 as directors only.
Named as of the 2026-03-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Consano Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Consano Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Consano Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Consano Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Consano Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (consanobio.com).
Each opens in a new tab, filled in for Consano Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/consano-bio-inc-form-d-26000001